Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
GPAT
Upturn stock rating

GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT)

Upturn stock rating
$10.66
Last Close (24-hour delay)
Profit since last BUY0.19%
upturn advisory
Consider higher Upturn Star rating
BUY since 3 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/14/2025: GPAT (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit 4.66%
Avg. Invested days 113
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 378.78M USD
Price to earnings Ratio 32.94
1Y Target Price -
Price to earnings Ratio 32.94
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 9.98 - 10.64
Updated Date 06/29/2025
52 Weeks Range 9.98 - 10.64
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.32

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -0.29%
Return on Equity (TTM) -

Valuation

Trailing PE 32.94
Forward PE -
Enterprise Value 378804678
Price to Sales(TTM) -
Enterprise Value 378804678
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 28750000
Shares Floating 24199953
Shares Outstanding 28750000
Shares Floating 24199953
Percent Insiders -
Percent Institutions 96.86

ai summary icon Upturn AI SWOT

GP-Act III Acquisition Corp. Class A Ordinary Share

stock logo

Company Overview

overview logo History and Background

GP-Act III Acquisition Corp. was a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It completed a business combination with Cyxtera Technologies in 2021.

business area logo Core Business Areas

  • Special Purpose Acquisition Company (SPAC): GP-Act III Acquisition Corp. focused on identifying and acquiring a business, effectively taking it public through a reverse merger. Prior to completing the business combination with Cyxtera Technologies, this was its sole business activity. It ceased to exist in its SPAC form after that combination.

leadership logo Leadership and Structure

As a SPAC, leadership would have consisted of executives with experience in deal-making and finance. The organizational structure was designed to efficiently manage the process of identifying, evaluating, and acquiring a target company. However, given its completion of the acquisition and renaming, the structure is no longer relevant to GP-Act III.

Top Products and Market Share

overview logo Key Offerings

  • SPAC Structure: GP-Act III offered investors the opportunity to participate in a potential merger with a private company. Success depended on the quality of the target acquired (Cyxtera Technologies). Market share data is not applicable to the SPAC structure itself. Competitors included other SPACs seeking target companies. The market share would have been equivalent to the final ownership percentage post Cyxtera acquisition. This is no longer a going entity.

Market Dynamics

industry overview logo Industry Overview

The SPAC industry involved competition among various blank check companies seeking attractive acquisition targets. Market conditions fluctuated based on investor sentiment and the availability of quality deals.

Positioning

GP-Act III aimed to differentiate itself by targeting a specific industry or leveraging the expertise of its management team. Its success depended on its ability to identify and complete a value-accretive acquisition.

Total Addressable Market (TAM)

The total addressable market was the aggregate valuation of private companies that are potential SPAC targets. GP-Act III's positioning was to identify an undervalued or high-growth potential company within this TAM. This is no longer a relevant metric.

Upturn SWOT Analysis

Strengths

  • Experienced management team
  • Access to capital
  • Ability to quickly complete acquisitions

Weaknesses

  • Dependence on finding suitable acquisition targets
  • Potential for overpaying for acquisitions
  • Dilution of shareholder value
  • SPAC structures in general are often criticized for benefiting sponsors more than public shareholders

Opportunities

  • Growing market for SPAC mergers
  • Increasing number of private companies seeking to go public
  • Potential to create value through operational improvements at acquired companies

Threats

  • Increased competition from other SPACs
  • Regulatory scrutiny of SPAC mergers
  • Economic downturns that could impact acquisition targets
  • Changes in investor sentiment towards SPACs

Competitors and Market Share

competitor logo Key Competitors

Competitive Landscape

The competitive landscape was the universe of other SPACs seeking acquisitions and the specific industry that Cyxtera participates in.

Growth Trajectory and Initiatives

Historical Growth: Historical growth is not applicable to the SPAC itself. It is tied to Cyxtera.

Future Projections: Future projections are related to Cyxtera Technologies

Recent Initiatives: Recent initiatives are related to Cyxtera Technologies.

Summary

GP-Act III Acquisition Corp. was a special purpose acquisition company (SPAC) that completed a business combination with Cyxtera Technologies. Its success was contingent on identifying and acquiring a valuable target. The SPAC market is highly competitive and subject to regulatory changes. Financial performance and shareholder returns are now tied to the operations of Cyxtera.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Press Releases
  • Financial News Outlets

Disclaimers:

This analysis is based on publicly available information and is not financial advice. Investing in SPACs carries significant risks. The information is historical given this SPAC no longer exists.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About GP-Act III Acquisition Corp. Class A Ordinary Share

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2024-07-01
CEO -
Sector Financial Services
Industry Shell Companies
Full time employees -
Full time employees -

GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. The company was incorporated in 2020 and is based in New York, New York.